Incisions for Cardiac Surgery
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00229892|
Recruitment Status : Terminated (after 90 charts reviewed, insufficient data to support conclusion)
First Posted : September 30, 2005
Last Update Posted : November 18, 2011
|Condition or disease|
|Cardiac Surgery Cardiac Diseases|
There is a trend in surgery, in general, toward minimal invasion. This includes the transition to laparoscopy/thoracoscopy from open procedures, as well as the reduction in incision size for open procedures. The goal of minimally invasive techniques is to reduce morbidity and length of hospital stay, with a consequent reduction in hospital cost.
There are few cardiac operations that are currently performed with minimally invasive techniques. One of these is the repair of an atrial septal defect, which can be performed though a small skin incision and partial rather than full sternotomy. Another is the ligation of a patent ductus arteriosus, which can be performed through a muscle-sparing thoracotomy rather than a full thoracotomy.
Both of these techniques minimize the scarring and the healing time required for post-operative recovery. We need to be confident that it has not affected our outcomes adversely. We need to evaluate our length of incisions based on patient weight, operative times, hospital lengths of stay, pain medicine requirements, complications and costs.
Hopefully, these data will lead to a new minimally invasive standard of care without a reduction in outcomes.
We will review charts before November 1, 2004 at Children's Healthcare of Atlanta.
|Study Type :||Observational|
|Actual Enrollment :||90 participants|
|Official Title:||Small Incisions for Cardiac Surgery|
|Study Start Date :||February 2005|
|Actual Study Completion Date :||September 2006|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00229892
|United States, Georgia|
|Children's Healthcare of Atlanta at Egleston|
|Atlanta, Georgia, United States, 30322|
|Principal Investigator:||Brian Kogon, MD||Emory University|